DMT210 Topical Gel in the Treatment of Atopic Dermatitis
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Psoriasis, Dermatology, Dermatology, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 12 - Any |
| Updated: | 6/9/2017 |
| Start Date: | October 2016 |
| End Date: | August 2017 |
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
The objective of the study is to evaluate the safety and efficacy of DMT210 Gel, 5% compared
to vehicle control following 28 days of twice-daily topical application to selected target
lesions in male and female patients with mild to moderate atopic dermatitis (AD).
to vehicle control following 28 days of twice-daily topical application to selected target
lesions in male and female patients with mild to moderate atopic dermatitis (AD).
Inclusion Criteria:
- Male or female 12 years or older
- Patient has chronic, stable AD that has been present for at least 3 months with 5-35%
(inclusive) BSA (Body Surface Area) of AD involvement
- Patient has two analogous, Target Lesions; one lesion within each of the two
Treatment Areas
- Patient is willing and able to comply with the protocol
Exclusion Criteria:
- Patient has used topical therapies for AD within the Treatment Areas 2 weeks before
baseline
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials